Kenta Ushida
Biographic Data
| ID | 9220691 |
|---|---|
| NAME | Kenta Ushida |
| GIVEN NAMES | Kenta |
| FAMILY NAME | Ushida |
| SIGNATURE | USHIDA K |
| AFFILIATIONS | Department of Rehabilitation Mie University Hospital Tsu Japan |
| ORCID | 0000-0001-7375-6835 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2026 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Hq5
M.A. has disclosed financial relationships with Daiichi Sankyo Co. Ltd., MSD K.K. Toa Eiyo Co. Ltd., Towa Pharmaceutical Co. Ltd., Eisai Co. Ltd., Kracie Pharmaceutical Co. Ltd., Tsumura Pharmaceutical Co. Ltd., Tanabe Mitsubishi Pharma Corporation, Chugai Pharmaceutical Co. Ltd., Ono Pharmaceutical Co. Ltd., Takeda Pharmaceutical Co. Ltd., Astellas Pharma Inc., Bayer Yakuhin Ltd.
Hq2
Conditions such as coronary artery disease, osteoarthritis, and cancer and its treatments are considered high risk for the onset of frailty, which may worsen disease responsiveness, activities of daily living (ADL), and life prognosis. Therefore, prevention of frailty in non-older adults at high risk holds significant individual and societal value. However, the evidence remains insufficient regarding whether digital health service interventions s…
No prominent works on this page.
Hq5
M.A. has disclosed financial relationships with Daiichi Sankyo Co. Ltd., MSD K.K. Toa Eiyo Co. Ltd., Towa Pharmaceutical Co. Ltd., Eisai Co. Ltd., Kracie Pharmaceutical Co. Ltd., Tsumura Pharmaceutical Co. Ltd., Tanabe Mitsubishi Pharma Corporation, Chugai Pharmaceutical Co. Ltd., Ono Pharmaceutical Co. Ltd., Takeda Pharmaceutical Co. Ltd., Astellas Pharma Inc., Bayer Yakuhin Ltd.
Hq2
Conditions such as coronary artery disease, osteoarthritis, and cancer and its treatments are considered high risk for the onset of frailty, which may worsen disease responsiveness, activities of daily living (ADL), and life prognosis. Therefore, prevention of frailty in non-older adults at high risk holds significant individual and societal value. However, the evidence remains insufficient regarding whether digital health service interventions s…
Digital health (2 works) · Frailty in Older Adults (2 works) · Guideline (2 works) · Nutrition and Health in Aging (2 works) · Psychological intervention (2 works) · Telemedicine (2 works) · Disease prevention (1 work) · Health care (1 work) · MEDLINE (1 work) · Mobile Health and mHealth Applications (1 work)